Formulation of lipid bearing pellets as a delivery system for poorly soluble drugs

International Journal of Pharmaceutics

Volumn 446, Issue 1-2, 2013, Pages 136-144

  Chopra, Shruti ^a   Venkatesan, Natarajan ^b   Betageri, Guru V ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^b MIDWESTERN UNIVERSITY   (United States)

Author keywords

Extrusion; Nisoldipine; Pellets; Solubility; Soy phosphatidylcholine; Spheronization

Indexed keywords

ALCOHOL; LACTOSE; MICROCRYSTALLINE CELLULOSE; NISOLDIPINE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; WATER;

ARTICLE; CHEMICAL STRUCTURE; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG PELLET; DRUG SOLUBILITY; ELECTRON MICROSCOPY; FLOW KINETICS; IN VITRO STUDY; MOISTURE; PARTICLE SIZE; PELLET EXTRUSION; PRIORITY JOURNAL; SPHERONIZATION; SYNTHESIS; TABLET FRIABILITY; THERMOSTABILITY;

CALCIUM CHANNEL BLOCKERS; CALORIMETRY, DIFFERENTIAL SCANNING; CELLULOSE; DRUG DELIVERY SYSTEMS; EXCIPIENTS; MICROSCOPY, ELECTRON, SCANNING; MODELS, THEORETICAL; NISOLDIPINE; PHOSPHATIDYLCHOLINES; SOLUBILITY; TABLETS;

EID: 84874582388     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.02.029     Document Type: Article

References (33)

1. M. Adane, T. Gebre-Mariam, G. Alderborn, and G. Frenning The use of extragranular disintegrants in multiple-unit tablet formulations: effect on compressibility, compactibility and disintegration J. Drug Deliv. Sci. Technol. 17 2007 279 284
2. R.W. Baker, and H.S. Lonsdale Controlled release: mechanisms and rates A.C. Taquary, R.E. Lacey, Controlled Release of Biologically Active Agents 1974 Plenum Press New York 15 71
3. A.W. Basit, F. Podczeck, J.M. Newton, W.A. Waddington, P.J. Ell, and L.F. Lacey The use of formulation technology to assess regional gastrointestinal drug absorption in humans Eur. J. Pharm. Sci. 21 2004 179 189
4. N. Charoenthai, P. Kleinebudde, and S. Puttipipatkhachorn Influence of chitosan type on the properties of extruded pellets with low amount of microcrystalline cellulose AAPS PharmSciTech 8 2007 E64
5. R. Chopra, F. Podczeck, J.M. Newton, and G. Alderborn The influence of pellet shape and film coating on the filling of pellets into hard shell capsules Eur. J. Pharm. Biopharm. 53 2002 327 333
6. P. Costa, J. Manuel, and S. Lobo Modeling and comparison of dissolution profiles Eur. J. Pharm. Sci. 13 2001 123 133
7. G.A. Digenis, E.P. Sandefer, A.F. Parr, R. Beihn, C. McClain, B.M. Scheinthal, I. Ghebre-Sellassie, U. Iyer, R.U. Nesbitt, and E. Randinitis Gastrointestinal behavior of orally administered radiolabeled erythromycin pellets in man as determined by gamma scintigraphy J. Clin. Pharmacol. 30 1990 621 631
8. G. Fricker, T. Kromp, A. Wendel, A. Blume, J. Zirkel, H. Rebmann, C. Setzer, R.O. Quinkert, F. Martin, and C. Muller-Goymann Phospholipids and lipid-based formulations in oral drug delivery Pharm. Res. 27 2010 1469 1486
9. L. Hasznos, I. Langer, and M. Gyarmathy Some factors influencing pellet characteristics made by an extrusion spheronisation process. Part I: effects on size characteristics and moisture content decrease of pellets Drug Dev. Ind. Pharm. 18 1992 409 437
10. R. Heinig Clinical pharmacokinetics of nisoldipine coat-core Clin. Pharmacokinet. 35 1998 191 208
11. T. Higuchi Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices J. Pharm. Sci. 52 1963 1145 1149
12. A.W. Hixson, and J.H. Crowell Dependence of reaction velocity upon surface and agitation Ind. Eng. Chem. 23 1931 923 931
13. P. Kleinebudde The crystallite-gel-model for microcrystalline cellulose in wet-granulation, extrusion, and spheronization Pharm. Res. 14 1997 804 809
14. P. Kleinebudde, M. Schröder, P. Schultz, B.W. Müller, T. Waaler, and L. Nymo Importance of the fraction of microcrystalline cellulose and spheronization speed on the properties of extruded pellets made from binary mixtures Pharm. Dev. Technol. 4 1999 397 404
15. R.W. Korsmeyer, and N.A. Peppas Effect of the morphology of hydrophilic polymeric matrices on the diffusion and release of water soluble drugs J. Membr. Sci. 9 1981 211 227
16. M.F. Law, and P.B. Deasy Use of hydrophilic polymers with microcrystalline cellulose to improve extrusion-spheronization Eur. J. Pharm. Biopharm. 45 1998 57 65
17. G.P. Millili, and J.B. Schwartz The strength of microcrystalline cellulose pellets-the effect of granulating with water ethanol mixtures Drug Dev. Ind. Pharm. 16 1990 1411 1426
18. J.W. Moore, and H.H. Flanner Mathematical comparison of curves with an emphasis on dissolution profiles Pharm. Technol. 20 1996 64 74
19. S. Paker-Leggs, and S.H. Neau Propranolol forms affect properties of carbopol-containing extruded-spheronized beads Int. J. Pharm. 361 2008 169 176
20. S. Paker-Leggs, and S.H. Neau Pellet characteristics and drug release when the form of propranolol is fixed as moles or mass in formulations for extruded and spheronized carbopol-containing pellets Int. J. Pharm. 369 2009 96 104
21. J.F. Pinto, G. Buckton, and J.M. Newton The influence of four selected processing and formulation factors on the production of spheres by extrusion and spheronisation Int. J. Pharm. 83 1993 187 196
22. F. Podczeck, S.R. Rahman, and J.M. Newton Evaluation of a standardised procedure to assess the shape of pellets using image analysis Int. J. Pharm. 192 1999 123 138
23. R.C. Rowe, P. York, E.A. Colbourn, and S.J. Roskilly The influence of pellet shape, size and distribution on capsule filling-a preliminary evaluation of three-dimensional computer simulation using a Monte-Carlo technique original research Int. J. Pharm. 300 2005 32 37
24. W. Sawicki Pharmacokinetics of verapamil and norverapamil from controlled release floating pellets in humans Eur. J. Pharm. Biopharm. 53 2002 29 35
25. J. Siepmann, and N.A. Peppas Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC) Adv. Drug Deliv. Rev. 48 2001 139 157
26. J.J. Sousa, A. Sousa, F. Podczeck, and J.M. Newton Influence of process conditions on drug release from pellets Int. J. Pharm. 144 1996 159 169
27. J.J. Sousa, A. Sousa, F. Podczeck, and J.M. Newton Factors influencing the physical characteristics of pellets obtained by extrusion-spheronization Int. J. Pharm. 232 2002 91 106
28. C. Souto, A. Rodriguez, S. Parajes, and R. Martínez-Pacheco A comparative study of the utility of two superdisintegrants in microcrystalline cellulose pellets prepared by extrusion-spheronization Eur. J. Pharm. Biopharm. 61 2005 94 99
29. M. Thommes, and P. Kleinebudde Properties of pellets manufactured by wet extrusion/spheronization process using kappa-carrageenan: effect of process parameters AAPS PharmSciTech 8 2007 E95
30. United States Pharmacopoeia-35-National Formulary-30, 2012. Online version.
31. S.C.L. Wan, P.W.S. Heng, and C.V. Liew Spheronization conditions on spheroid shape and size Int. J. Pharm. 96 1993 59 65
32. M. Yasir, M. Asif, A. Kumar, and A. Aggarval Biopharmaceutical classification system: an account Int. J. Pharm. Tech. Res. 2 2010 1681 1690
33. F. Zeeshan, and N.I. Bukhari Development and evaluation of a novel modified-release pellet-based tablet system for the delivery of loratadine and pseudoephedrine hydrochloride as model drugs AAPS PharmSciTech 11 2010 910 916